These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 35590292)
1. DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer. Zhang M; Peng Y; Yang Z; Zhang H; Xu C; Liu L; Zhao Q; Wu J; Wang H; Liu J BMC Cancer; 2022 May; 22(1):561. PubMed ID: 35590292 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2. Zhu XH; Wang JM; Yang SS; Wang FF; Hu JL; Xin SN; Men H; Lu GF; Lan XL; Zhang D; Wang XY; Liao WT; Ding YQ; Liang L Int J Cancer; 2017 Jul; 141(1):172-183. PubMed ID: 28335083 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP. Xiao Y; Li ZH; Bi YH Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3326-3334. PubMed ID: 31081086 [TBL] [Abstract][Full Text] [Related]
4. miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP. Li X; Zhang X; Zhang Q; Lin R Int J Biochem Cell Biol; 2019 Jun; 111():27-36. PubMed ID: 30974224 [TBL] [Abstract][Full Text] [Related]
5. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer. Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738 [TBL] [Abstract][Full Text] [Related]
6. The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer. Wang J; Zhu X; Hu J; He G; Li X; Wu P; Ren X; Wang F; Liao W; Liang L; Ding Y Oncotarget; 2015 Sep; 6(29):27427-39. PubMed ID: 26336990 [TBL] [Abstract][Full Text] [Related]
7. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation. Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646 [TBL] [Abstract][Full Text] [Related]
8. [Knock-down of DAB2 interacting protein (DAB2IP) promotes proliferation and inhibits apoptosis of bladder cancer cells]. Zhang K; Wang W; Wu K; Ding C; Zhu J; DU Y; Guan Z; Wang X; Fan J Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):668-676. PubMed ID: 28502307 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells. Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215 [TBL] [Abstract][Full Text] [Related]
10. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein. Chen S; Wang L; Yao B; Liu Q; Guo C Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165 [TBL] [Abstract][Full Text] [Related]
11. DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer. Feng S; Huang Q; Deng J; Jia W; Gong J; Xie D; Shen J; Liu L Cancer Lett; 2022 Apr; 532():215588. PubMed ID: 35150809 [TBL] [Abstract][Full Text] [Related]
12. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression. Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444 [TBL] [Abstract][Full Text] [Related]
13. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma. Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation. Yun EJ; Lin CJ; Dang A; Hernandez E; Guo J; Chen WM; Allison J; Kim N; Kapur P; Brugarolas J; Wu K; He D; Lai CH; Lin H; Saha D; Baek ST; Chen BPC; Hsieh JT Clin Cancer Res; 2019 Jul; 25(14):4542-4551. PubMed ID: 31000589 [TBL] [Abstract][Full Text] [Related]
15. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Liu Z; Yu Y; Huang Z; Kong Y; Hu X; Xiao W; Quan J; Fan X Cell Death Dis; 2019 Nov; 10(12):900. PubMed ID: 31776329 [TBL] [Abstract][Full Text] [Related]
16. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells. Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909 [TBL] [Abstract][Full Text] [Related]
17. DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer. Wu G; Xu X; Wan D; Zhou D; Feng Y; Chen J; Peng Z; Fang D; Shi X; Yao H; Chen G; Sun L; Yao Y; Zhou G; Yang Y; He S Ann Transl Med; 2021 Aug; 9(16):1317. PubMed ID: 34532454 [TBL] [Abstract][Full Text] [Related]
18. The mechanism of DAB2IP in chemoresistance of prostate cancer cells. Wu K; Xie D; Zou Y; Zhang T; Pong RC; Xiao G; Fazli L; Gleave M; He D; Boothman DA; Hsieh JT Clin Cancer Res; 2013 Sep; 19(17):4740-9. PubMed ID: 23838317 [TBL] [Abstract][Full Text] [Related]
19. AHA1 regulates cell migration and invasion via the EMT pathway in colorectal adenocarcinomas. Kim D; Moon JW; Min DH; Ko ES; Ahn B; Kim ES; Lee JY Sci Rep; 2021 Oct; 11(1):19946. PubMed ID: 34620942 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer. Liu F; Li X; Yan H; Wu J; Yang Y; He J; Chen J; Jiang Z; Wu F; Jiang Z Cell Signal; 2022 Apr; 92():110267. PubMed ID: 35108639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]